[New post] UOBKH: Sino Biopharmaceutical

alanyeo posted: " 1H21: Results In Line; Aims To Become A Significant Global Drug Innovator Sino Biopharm's reported revenue grew 13.5% yoy and adjusted net earnings increased 22.9% yoy in 1H21. The results are in line with our estimates. Supported by new product launc" Respond to this post by replying above this line New post on Alpha Edge Investing UOBKH: Sino Biopharmaceutical by alanyeo 1H21: Results In Line; Aims To Become A Significant Global Drug Innovator Sino Biopharm's reported revenue grew 13.5% yoy and adjusted net earnings increased 22.9% yoy in 1H21. The results are in line with our estimates. Supported by new product launches, the company is likely to generate steady revenue growth of approximately 18.4% CAGR in […] Read more of this post This post is ad-supported ​ alanyeo | September 1, 2021 at 2:53 pm | Categories: Equities - Research Reports by Brokers/ Banks | URL: https://wp.me/p7fA1-3uI Comment    See all comments    Like Unsubscribe to no longer receive posts from Alpha Edge Investing. Change your email settings at Manage Subscriptions. Trouble clicking? Copy and paste this URL into your browser: http://alphaedgeinvesting.com/2021/09/01/uobkh-sino-biopharmaceutical-2/ Thanks for flying with WordPress.com